14.3 Mass Casualty Incidents, CBRNE Countermeasures & Strategic Stockpiles

14.3 Mass Casualty Incidents, CBRNE Countermeasures & Strategic Stockpiles

Mass Casualty Incidents (MCIs) & Disaster Triage Frameworks

A Mass Casualty Incident (MCI) occurs when the number, severity, and diversity of arriving casualties overwhelm the local emergency medical infrastructure, staffing, and pharmaceutical reserves. In everyday emergency practice, healthcare teams operate under an individual-centered ethical framework, deploying exhaustive resources to achieve optimal outcomes for every single patient. In an MCI, medical ethics fundamentally shift to a utilitarian population-based framework: doing the greatest good for the greatest number of viable casualties with the available resources.

The START Triage System (Adults)

The Simple Triage and Rapid Treatment (START) algorithm is the most widely adopted field and hospital-entry triage model. It systematically categorizes casualties into four color-coded operational designations in under 60 seconds per patient using three clinical assessments: Respirations, Perfusion, and Mental Status (RPM).

                         START DISASTER TRIAGE ALGORITHM
  ┌─────────────────────────────────────────────────────────────────────────────┐
  │ Step 1: Initial Global Sorting                                              │
  │ Direct all ambulatory casualties to walk to a designated secondary area.   │
  │ All walking patients ──────────────────────────────────────────► GREEN (Minor)│
  └──────────────────────────────────────┬──────────────────────────────────────┘
                                         ▼
                     Step 2: Evaluate Spontaneous Respirations
                                         │
                 ┌───────────────────────┴───────────────────────┐
                 ▼ APNEIC                                        ▼ PRESENT
  ┌───────────────────────────────┐              ┌───────────────────────────────┐
  │ Reposition Upper Airway       │              │ Respiratory Rate Check        │
  │ Still Apneic ──► BLACK (Dead) │              │ > 30 breaths/min ──► RED (Imm)│
  │ Resumes Breathing ─► RED (Imm)│              │ < 30 breaths/min ──► Assess P │
  └───────────────────────────────┘              └───────────────┬───────────────┘
                                                                 ▼
                                                     Step 3: Assess Perfusion
                                                                 │
                                 ┌───────────────────────────────┴───────────────┐
                                 ▼ ABSENT RADIAL / CAP REFILL > 2s               ▼ PRESENT
                  ┌───────────────────────────────┐              ┌───────────────┴───────────────┐
                  │ Control Bleeding ──► RED (Imm)│              │ Step 4: Assess Mental Status  │
                  └───────────────────────────────┘              │ Cannot Follow Commands ─► RED │
                                                                 │ Follows Commands ──► YELLOW   │
                                                                 └───────────────────────────────┘

Color-Coded Triage Categories

• RED (Immediate): Critical, life-threatening injuries or physiological instability requiring immediate intervention within minutes to survive (e.g., tension pneumothorax, respiratory rate >30, signs of shock, uncontrolled arterial bleeding). Highest treatment and transport priority.
• YELLOW (Delayed): Serious injuries requiring medical intervention within hours, but physiological status is currently stable without imminent threat to life or limb (e.g., stable long-bone fractures, large soft tissue lacerations without hemorrhagic shock, normal RPM parameters).
• GREEN (Minor / Walking Wounded): Ambulatory patients with minor abrasions, sprains, or contusions. Directed to remote treatment sectors to prevent crowding of acute resuscitation bays.
• BLACK (Expectant / Deceased): Patients who are deceased (apneic despite airway repositioning) or whose injuries are so catastrophic (e.g., 95% third-degree burns, open traumatic brain injury with extruded cerebral tissue) that survival is improbable given available medical resources during an active disaster. Provided palliative comfort care if resources permit.

The SALT Triage Framework

The SALT (Sort, Assess, Lifesaving Interventions, Triage/Treat) algorithm enhances START by incorporating early, rapid lifesaving interventions before assigning final triage status:

1. Global Sorting: Sort casualties into groups based on voice commands (1: walk to area [assessed third]; 2: wave or purposeful movement [assessed second]; 3: still or obvious life threat [assessed first]).
2. Lifesaving Interventions: Perform immediate, rapid interventions: apply tourniquet for catastrophic extremity hemorrhage, open airway (provide 2 rescue breaths for apneic pediatric patients), perform needle thoracostomy for tension pneumothorax, and administer immediate antidote auto-injectors (e.g., nerve agent antidotes).
3. Individual Triage: Assign category: Immediate (Red), Delayed (Yellow), Minimal (Green), Expectant (Gray), or Dead (Black).

---

Chemical Warfare Agents: Nerve Agents & Cyanide

Chemical threats represent high-velocity toxicological emergencies requiring immediate personal protective equipment (PPE Level C or B) and rapid empiric antidote administration.

Chemical Nerve Agents (Sarin, Soman, Tabun, VX)

• Mechanism: Nerve agents are highly potent, organophosphate chemical compounds that irreversibly bind to and inhibit the enzyme acetylcholinesterase (AChE). This leads to massive, uncontrolled accumulation of acetylcholine at postganglionic parasympathetic muscarinic receptors, skeletal neuromuscular nicotinic junctions, and central nervous system synapses.
• Clinical Presentation: Severe cholinergic crisis remembered by SLUDGEM (Salivation, Lacrimation, Urination, Defecation, Gastrointestinal distress, Emesis, Miosis) or DUMBELS (Defecation, Urination, Miosis, Bradycardia/Bronchorrhea/Bronchospasm, Emesis, Lacrimation, Salivation). The primary cause of death is the "Killer B's": Bronchorrhea, Bronchospasm, and severe Bradycardia, compounded by diaphragmatic muscle paralysis and central apnea.
• Mark I Autoinjector Kit / DuoDote:
  • Atropine (2 mg autoinjector): A competitive muscarinic receptor antagonist that crosses the blood-brain barrier. It dries copious bronchial secretions, relieves severe bronchoconstriction, and restores heart rate. Administration Endpoint: Atropine is titrated aggressively until pulmonary secretions are completely dry and airway resistance clears ("atropinization"). Heart rate and pupil size are unreliable endpoints. Note: Atropine has zero activity at nicotinic receptors and therefore does not reverse skeletal muscle weakness or diaphragmatic paralysis.
  • Pralidoxime Chloride (2-PAM, 600 mg autoinjector): A nucleophilic oxime that uncouples the organophosphate molecule from acetylcholinesterase, reactivating the enzyme. It acts primarily at nicotinic junctions to restore skeletal muscle strength and reverse diaphragmatic paralysis. The Aging Phenomenon: Once the chemical bond between the nerve agent and acetylcholinesterase undergoes covalent dealkylation ("aging"), 2-PAM can no longer reactivate the enzyme. Soman ages within 2 minutes; sarin ages in ~5 hours; VX ages in ~40 hours. Thus, 2-PAM must be administered immediately upon exposure.
• CANA (Convulsive Antidote, Nerve Agent):
  • Contains Diazepam 10 mg autoinjector (or Midazolam 10 mg autoinjector). Nerve agent toxicity triggers severe, continuous status epilepticus driven by excessive central cholinergic and glutamatergic firing. Conventional anticonvulsants (phenytoin) are completely ineffective. High-dose GABA-A receptor agonists (benzodiazepines) must be administered immediately with the first dose of atropine/2-PAM to prevent permanent excitotoxic cerebral necrosis.

Cyanide Mass Casualty

• Mechanism: Cyanide (hydrogen cyanide gas, potassium cyanide) rapidly binds with high affinity to the ferric iron (Fe3+) in cytochrome c oxidase (complex IV) of the mitochondrial electron transport chain. This halts oxidative phosphorylation, arrests cellular aerobic respiration, and shifts cellular metabolism to anaerobic glycolysis, causing profound lactic acid generation.
• Clinical Presentation: Rapid onset of headache, confusion, seizures, coma, respiratory arrest, cardiovascular collapse, and severe metabolic acidosis with an elevated serum lactate (>8 to 10 mmol/L). Because tissues cannot extract oxygen from arterial blood, venous blood remains fully oxygenated, producing a bright red appearance of venous blood and high central venous oxygen saturation (SvO2 >85-90%).
• Hydroxocobalamin (Cyanokit 5 g IV over 15 minutes):
  • First-Line Antidote: Hydroxocobalamin contains a central cobalt atom that binds cyanide with higher affinity than cytochrome oxidase, forming non-toxic cyanocobalamin (vitamin B12), which is safely eliminated in the urine. A second 5 g infusion may be administered over 15 minutes to 2 hours for refractory shock (total 10 g).
  • Safety in Smoke Inhalation: Hydroxocobalamin does not induce methemoglobinemia. It is completely safe to administer to victims of structural fires where concurrent carbon monoxide (CO) poisoning and carboxyhemoglobinemia are suspected. (Adverse effects: reddish skin and mucosal discoloration, chromaturia, transient hypertension).
  • Comparison with Sodium Nitrite: Traditional cyanide antidote kits contain sodium nitrite and sodium thiosulfate. Sodium nitrite oxidizes hemoglobin to methemoglobin (Fe3+), which binds cyanide to form cyanmethemoglobin. Sodium nitrite is contraindicated in smoke inhalation victims because methemoglobinemia further decreases oxygen-carrying capacity in patients with co-existing carboxyhemoglobinemia, precipitating fatal cellular hypoxia.

---

Biological Threat Agents: Anthrax, Botulism & Plague

Biological weapons utilize pathogenic microorganisms or toxins deliberately disseminated to cause widespread disease, panic, and societal disruption.

Inhalation Anthrax (Bacillus anthracis)

• Microbiology & Pathophysiology: Bacillus anthracis is a Gram-positive, spore-forming, rod-shaped bacterium. Inhaled spores are engulfed by pulmonary alveolar macrophages and transported to mediastinal lymph nodes, where they germinate into vegetative bacilli and produce lethal toxin and edema toxin. This causes severe, necrotizing hemorrhagic mediastinitis, non-cardiogenic pulmonary edema, and refractory septic shock.
• Chest Radiograph Hallmark: Marked widening of the mediastinum and bilateral pleural effusions without parenchymal infiltrates.
• Post-Exposure Prophylaxis (PEP): Inhaled spores can remain dormant in lung parenchyma for months. PEP requires a continuous 60-day oral course:
  • Ciprofloxacin 500 mg PO every 12 hours, OR
  • Doxycycline 100 mg PO every 12 hours.
• Active Systemic Disease Regimen:
  • Must utilize triple intravenous antimicrobial therapy: at least two bactericidal agents with distinct mechanisms plus one protein-synthesis inhibitor to shut down toxin production:
    • Agent 1 (Bactericidal): Ciprofloxacin 400 mg IV every 8 hours (or Levofloxacin 750 mg IV q24h).
    • Agent 2 (Bactericidal): Meropenem 2 g IV every 8 hours (extended infusion).
    • Agent 3 (Protein Synthesis Inhibitor): Clindamycin 900 mg IV every 8 hours OR Linezolid 600 mg IV every 12 hours.
    • Antitoxin Therapy: Add monoclonal antitoxins targeting protective antigen: Raxibacumab, Obiltoxaximab, or Anthrax Immune Globulin Intravenous (AIGIV).

Botulism (Clostridium botulinum)

• Pathophysiology: Clostridium botulinum neurotoxin is the most lethal biological toxin known. The toxin cleaves SNARE proteins (synaptobrevin, SNAP-25, syntaxin) in presynaptic motor nerve terminals, permanently blocking the vesicular release of acetylcholine at neuromuscular junctions.
• Clinical Presentation: Symmetric, descending, flaccid paralysis that begins with cranial nerve deficits (the 4 D's: Diplopia, Dysarthria, Dysphonia, Dysphagia; plus ptosis and blurred vision) and progresses downward to the upper extremities, diaphragm, and lower extremities. Mentation and sensory exam remain entirely intact; fever is characteristically absent.
• Antidote Pharmacotherapy:
  • Heptavalent Botulinum Antitoxin (HBAT): Contains equine-derived antibody fragments neutralizing toxin serotypes A, B, C, D, E, F, and G. HBAT neutralizes only unbound circulating neurotoxin in the bloodstream; it cannot reverse paralysis once toxin has internalized into presynaptic nerve terminals. Early administration arrests progression, but clinical recovery requires weeks to months for nerve terminals to regenerate synapses. Meticulous mechanical ventilatory support is the cornerstone of survival.

Pneumonic Plague (Yersinia pestis)

• Pathophysiology & Transmission: Yersinia pestis is a Gram-negative coccobacillus. Pneumonic plague is transmitted person-to-person via respiratory droplets, producing fulminant necrotizing pneumonia, hemoptysis, and overwhelming endotoxic shock.
• Therapeutic Regimens:
  • First-line: Aminoglycosides—Streptomycin 1 g IM every 12 hours or Gentamicin 5 mg/kg IV once daily (or 1.7 mg/kg IV q8h).
  • Alternatives: Ciprofloxacin 400 mg IV every 8 hours or Levofloxacin 750 mg IV every 24 hours.
  • Post-Exposure Prophylaxis: Doxycycline 100 mg PO twice daily or Ciprofloxacin 500 mg PO twice daily for 7 days.

---

Radiological & Nuclear Countermeasures

Radiological mass casualties arise from nuclear detonations, reactor core melt-downs, or radiological dispersal devices ("dirty bombs"). Management involves immediate external physical decontamination (removing clothing removes ~90% of external contamination, followed by warm water washing) and administration of radioisotope-specific decorporation and blocking agents.

Radioisotope-Specific Decorporation & Blocking Agents

1. Potassium Iodide (KI):
   • Target Radioisotope: Radioactive Iodine-131 (131I) and related isotopes released during nuclear fission reactions.
   • Mechanism: Ingestion of non-radioactive potassium iodide floods the bloodstream, saturating the thyroid sodium-iodide symporter (NIS). This competitively blocks the thyroid uptake of inhaled or ingested radioactive iodine-131 by >98%, preventing radiation-induced thyroid carcinoma.
   • Administration Dosing:
     • Adults and adolescents >68 kg: 130 mg PO once daily.
     • Children 3 to 18 years (<68 kg): 65 mg PO once daily.
     • Infants 1 month to 3 years: 32 mg PO once daily.
     • Neonates (birth to 1 month): 16 mg PO single dose.
   • Timing & Limitations: KI must be administered prior to or immediately following exposure (ideally within 2 to 4 hours; minimal protective efficacy after 24 hours). Crucial Clinical Point: Potassium iodide protects exclusively against thyroid uptake of radioactive iodine. It provides zero protection against any other radioisotope (e.g., cesium, strontium, plutonium) and zero protection against external whole-body gamma or neutron radiation.
2. Prussian Blue (Insoluble Ferric Hexacyanoferrate, Radiogardase):
   • Target Radioisotopes: Cesium-137 (137Cs) and non-radioactive or radioactive Thallium (201Tl).
   • Mechanism: Taken orally, Prussian blue acts as an ion exchanger in the gastrointestinal tract, binding cesium and thallium in the intestinal lumen to form insoluble crystal complexes. This interrupts enterohepatic recirculation and accelerates fecal excretion, reducing the biological half-life of cesium-137 from ~110 days to ~30 days.
   • Dosing: 3 g PO three times daily (adults); 1 g PO three times daily (children 2 to 12 years).
3. DTPA (Diethylenetriaminepentaacetic Acid):
   • Target Radioisotopes: Internal contamination with transuranic actinides: Plutonium (Pu), Americium (Am), and Curium (Cm).
   • Mechanism: DTPA forms stable, water-soluble coordination chelates with transuranic actinides, which are then rapidly excreted by glomerular filtration in the urine.
   • Calcium-DTPA (Ca-DTPA): 1 g IV or nebulized inhalation. Far more effective than Zn-DTPA when administered within the first 24 hours post-contamination.
   • Zinc-DTPA (Zn-DTPA): 1 g IV or nebulized inhalation. Used for maintenance chelation therapy after the initial 24 hours, or as the initial agent in pregnant patients (Ca-DTPA causes depletion of essential endogenous zinc and manganese minerals and is teratogenic with prolonged administration, whereas Zn-DTPA is significantly safer for prolonged use).

---

CBRNE Antidote & Countermeasure Matrix

---

Strategic National Stockpile (SNS) Architecture & Surge Logistics

The Strategic National Stockpile (SNS), managed by the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), maintains massive repositories of pharmaceuticals, medical countermeasures, vaccines, and airway equipment designed to protect the American public during major public health emergencies.

12-Hour Push Packages

• Design & Deployment: 12-Hour Push Packages are 50-ton, pre-packaged, containerized caches of broad-spectrum antibiotics, chemical antidotes, IV fluid supplies, airway kits, and wound dressings strategically pre-positioned in climate-controlled warehouses across the United States. They are designed to be loaded onto cargo transport and arrive at any designated domestic airfield within 12 hours of a federal deployment decision.
• Vendor-Managed Inventory (VMI): Once the immediate push package is delivered, subsequent replenishment waves are supplied through Vendor-Managed Inventory (VMI) contracts, delivering specific pharmaceuticals matched to the identified biological or chemical threat.

The CHEMPACK Forward-Deployed Program

Because nerve agent poisoning produces death from respiratory arrest within minutes to hours, victims cannot wait for 12-Hour Push Packages to arrive from federal warehouses. The CDC established the CHEMPACK program—a nationwide network of forward-deployed, climate-controlled chemical antidote containers pre-positioned directly in local hospitals and emergency medical service (EMS) depots:

• Hospital CHEMPACK Containers: Contain approximately 1,000 casualty treatments. Configured with a higher proportion of multi-dose vials (e.g., atropine vials, bulk pralidoxime, multi-dose midazolam) suited for sustained inpatient care, ventilator beds, and continuous bedside medical resuscitation.
• EMS CHEMPACK Containers: Contain approximately 450 casualty treatments. Configured with a higher proportion of prefilled autoinjectors (Mark I / DuoDote, CANA diazepam autoinjectors) for immediate, rapid administration in the warm zone, triage sectors, and initial field resuscitation.
• Deployment Authority: CHEMPACK containers are secured with continuous remote temperature-monitoring sensors and electronic seal alarms. Local hospital incident commanders, emergency physicians, or emergency medical directors hold immediate legal authority to break container seals and release antidotes without waiting for federal approval whenever an organophosphate or nerve agent mass exposure is confirmed.

ED Operational Surge Capacity: The "4 S's"

To rapidly accommodate massive casualty inflows, emergency departments utilize the established "4 S's" disaster framework:

1. Staff: Mobilizing off-duty clinical personnel, activating physician and nursing labor pools, assigning emergency pharmacists to bedside antidote staging areas, and shifting to altered standards of care.
2. Stuff: Ensuring immediate access to disaster supply carts, personal protective equipment (PPE), mechanical ventilators, chest tubes, and rapid infusion devices; inventorying existing on-hand antidotes while requesting CHEMPACK container unsealing.
3. Space: Rapidly converting outpatient clinics, post-anesthesia care units (PACU), and hallway corridors into acute treatment bays; erecting external decontamination tents and triage sorting pavilions outside the physical ED entrance to prevent facility contamination.
4. Systems: Activating the Hospital Incident Command System (HICS), establishing clear incident command roles, transitioning electronic health records to disaster documentation modes, and coordinating real-time regional communications through regional healthcare disaster coalitions.